99mTc-Antimicrobial peptides: Promising candidates for infection imaging

Quarterly Journal of Nuclear Medicine

Volumn 47, Issue 4, 2003, Pages 238-245

  Lupetti, A ^a,b   Pauwels, E K J ^a   Nibbering, P H ^a   Welling, M M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Antimicrobial peptides; Infection, radionuclide imaging; Inflammation; Technetium

Indexed keywords

ALPHA DEFENSIN; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; BETA DEFENSIN; BOMBININ; CATHELICIDIN; CECROPIN; CIPROFLOXACIN; CYTOKINE; DERMASEPTIN; DROSOCIN; DROSOMYCIN; FLUCONAZOLE; GAMMA INTERFERON; HISTATIN; INTERLEUKIN 1; LACTOFERRIN; LIPOPOLYSACCHARIDE; MAGAININ DERIVATIVE; PEDIOCIN; PROTEGRIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RADIOPHARMACEUTICAL AGENT; RANALEXIN; SYNTHETIC PEPTIDE; TACHYPLESIN; TECHNETIUM 99M; THIONINE; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE; DIAGNOSTIC AGENT; RIBOSOMAL PROTEIN S30; RIBOSOME PROTEIN; TECHNETIUM DERIVATIVE;

BACTERIAL INFECTION; DIAGNOSTIC IMAGING; DRUG EFFICACY; GOOD LABORATORY PRACTICE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LABORATORY TEST; MAMMAL CELL; MICROORGANISM; MONITORING; MOUSE; MYCOSIS; NONHUMAN; NUCLEAR MEDICINE; PROTEIN BINDING; PROTEIN DOMAIN; RADIOACTIVITY; REVIEW; URINARY TRACT; ANIMAL; DIFFERENTIAL DIAGNOSIS; INFECTION; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; RABBIT; RADIOIMMUNOASSAY; RAT; SCINTISCANNING; TISSUE DISTRIBUTION;

ALPHA-DEFENSINS; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; DIAGNOSIS, DIFFERENTIAL; HUMANS; INFECTION; LACTOFERRIN; METABOLIC CLEARANCE RATE; MICE; RABBITS; RADIOIMMUNODETECTION; RADIOPHARMACEUTICALS; RATS; RIBOSOMAL PROTEINS; TECHNETIUM COMPOUNDS; TISSUE DISTRIBUTION;

EID: 1842421871     PISSN: 11243937     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. van Langevelde P, Joop K, van Loon J, Frolich M, Groeneveld PH, Westendorp RG et al. Endotoxin, cytokines, and procalcitonin in febrile patients admitted to the hospital: identification of subjects at high risk of mortality. Clin Infect Dis 2000;31:1343-8.
2. Becker W, Meller J. The role of nuclear medicine in infection and inflammation. Lancet Infect Dis 2001;1:326-33.
3. 99mTc-sulesomab in inflammation. J Nucl Med 2003;44:11-8.
4. Vallabhajosula S. Technetium-99m-labeled chemotactic peptides: specific for imaging infection? J Nucl Med 1997;38:1322-6.
5. 99mTc-labelled peptide-based radiopharmaceuticals: an overview. Nucl Med Commun. 1999;20: 1093-112.
6. 99mTc-Infecton, a novel agent for detecting sites of infection. J Clin Pathol 1998;51:215-9.
7. 99mTc-ciprofloxacin scintigraphy in a rabbit model of Staphylococcus aureus prosthetic joint infection. J Nucl Med 2002;43:239-45.
8. Dumarey N, Blocklet D, Appelboom T, Tant L, Schoutens A. Infecton is not specific for bacterial osteo-articular infective pathology. Eur J Nucl Med 2002;29:530-5.
9. 18F-labeled fluconazole in rabbits with candidal infections studied with positron emission tomography. J Pharmacol Exp Ther 1991;259:1351-9.
10. Lupetti A, Welling MM, Mazzi U, Nibbering PH, Pauwels EKJ. Technetium-99m labelled fluconazole and antimicrobial peptides for imaging of Candida albicans and Aspergillus fumigatus infections. Eur J Nucl Med 2002;29:674-9.
11. Hancock RE. Peptide antibiotics. Lancet 1997;349:418-22.
12. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002;415:389-95.
13. Berkel PHC van, Welling MM, Geerts M, Veen HA van, Ravensbergen B, Salaheddine M et al. Large scale production of recombinant human lactoferrin in the milk of transgenic cows. Nat Biotech 2002;20:484-7.
14. 99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections. J Nucl Med 2001;42:788-94.
15. 99mTc-labeled human neutrophil peptide-1. J Nucl Med 1999;40: 2073-80.
16. Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill J, Dorschner RA et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001;414:454-7.
17. Nibbering PH, Ravensbergen E, Welling MM, van Berkel LA, van Berkel PH, Pauwels EKJ et al. Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria. Infect Immun 2001;69: 1469-76.
18. Welling MM, Hiemstra PS, van den Barselaar Mr, Paulusma-Annema A, Nibbering PH, Pauwels EKJ et al. Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by increased leukocyte accumulation. J Clin Invest 1998;102:1583-90.
19. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J et al. β-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999;286:525-8.
20. Biragyn A, Ruffini PA, Leifer CA, Klyushnenkova E, Shakhov A, Chertov O et al. Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2. Science 2002;298:1025-9.
21. Piers KL, Brown MH, Hancock RE. Recombinant DNA procedures for producing small antimicrobial cationic peptides in bacteria. Gene 1993;134:7-13.
22. Rao AG, Rood T, Maddox J, Duvick J. Synthesis and characterization of defensin NP-1. Int J Pept Protein Res 1992;40:507-14.
23. Aumelas A, Mangoni M, Roumestand C, Chiche L, Despaux E, Grassy G et al. Synthesis and solution structure of the antimicrobial peptide protegrin-1. Eur J Biochem 1996;237:575-83.
24. Maloy WL, Kari UP. Structure-activity studies on magainins and other host defense peptides. Biopolymers 1995;37:105-22.
25. Blok D, Feitsma RI, Vermeij P, Pauwels EKJ. Peptide radiopharmaceuticals in nuclear medicine. Eur J Nucl Med 1999;26:1511-9.
26. Hnatowich DJ, Qu T, Chang F, Ley AC, Ladner RC, Rusckowski M. Labeling peptides with technetium-99m using a bifunctional chelator of a N-hydroxysuccinimide ester of mercaptoacetyltriglycine. J Nucl Med 1998;39:56-64.
27. 99mTc-labeled chemotactic peptides for studies of inflammation in vivo. Bioconjug Chem 1998;9:208-17.
28. 99mTc: a new direct method employing KBH4 and stannous chloride. Nucl Med Biol 1993;20:825-33.
29. 99mTc-UBI 29-41 for imaging of bacterial infections. Nucl Med Biol 2002;29:413-22.
30. 99mTc-labeling experiments on CCK(4) by a direct method. Nucl Med Biol 2001;28:865-73.
31. Reyes VE, Phillips L, Humphreys RE, Lew RA. Prediction of protein helices with a derivative of the strip-of-helix hydrophobicity algorithm. J Biol Chem 1989;264:12854-8.
32. Chou PY, Fasman GD. Prediction of protein conformation. Biochemistry 1974;13:222-45.
33. Welling MM, Paulusma-Annema A, Balter HS, Pauwels EKJ, Nibbering PH. Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations. Eur J Nucl Med 2000;27:292-301.
34. Tani K, Murphy WJ, Chertov O, Salcedo R, Koh CY, Utsunomiya I et al. Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens. Int Immunol 2000;12:691-700.
35. Nibbering PH, Paulusma-Annema A, Lupetti A, Brouwer CPJM, Welling MM, Pauwels EKJ. Technetium-99m labeled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus. J Nucl Med 2004, in press.
36. 99mTechnetium [abstract]. Eur J Nucl Med 2002;29:S366.